Short interest screen · refreshed after the Sep 28, 2026 close
Highest days to cover: Healthcare
Short positions that would take the longest to unwind at normal trading volume. Days to cover divides the shares sold short by average daily volume. A higher number means short sellers would need more time to buy back shares, which can make a rally sharper.
| # | Company | Price | Today | Days to cover | Short % float | Δ short int. | Mkt cap |
|---|---|---|---|---|---|---|---|
| 151 | DTILPrecision BioSciencesHealthcare | $6.24 | +0.32% | 10.6 | 9.2% | −12% | $172.2M |
| 152 | CYTKCytokineticsHealthcare | $66.16 | +2.32% | 10.6 | 14.4% | 0% | $9.20B |
| 153 | BBIOBridgeBio PharmaHealthcare | $66.61 | +1.59% | 10.5 | 13.4% | −1% | $13.02B |
| 154 | RCELAvita MedicalHealthcare | $11.67 | −1.44% | 10.5 | 9.6% | −2% | $360.9M |
| 155 | FATEFate TherapeuticsHealthcare | $2.38 | +1.28% | 10.5 | 9.2% | +3% | $285.2M |
| 156 | TCMDTactile Systems TechnologyHealthcare | $22.82 | +0.40% | 10.4 | 12.8% | +8% | $516.9M |
| 157 | MAZEMaze TherapeuticsHealthcare | $26.85 | +3.07% | 10.4 | 14.2% | −4% | $1.49B |
| 158 | TVTXTravere TherapeuticsHealthcare | $61.57 | +3.58% | 10.4 | 14.4% | +8% | $5.80B |
| 159 | TARAProtara TherapeuticsHealthcare | $3.25 | −0.91% | 10.3 | 8.1% | 0% | $192.1M |
| 160 | CADLCandel TherapeuticsHealthcare | $11.19 | +1.54% | 10.3 | 22.1% | +1% | $856.2M |
| 161 | ANABAnaptysBioHealthcare | $50.80 | −0.39% | 10.3 | 31.1% | 0% | $1.52B |
| 162 | COYACoya TherapeuticsHealthcare | $4.98 | −1.97% | 10.2 | 6.8% | +9% | $116.8M |
| 163 | FTREFortrea HoldingsHealthcare | $20.06 | +0.85% | 10.2 | 13.3% | +5% | $1.91B |
| 164 | BKDBrookdale Senior LivingHealthcare | $11.04 | −0.63% | 10.2 | 19.2% | +11% | $2.64B |
| 165 | BBNXBeta BionicsHealthcare | $20.52 | −4.60% | 9.9 | 37.4% | +13% | $1.11B |
| 166 | CORTCorcept TherapeuticsHealthcare | $115.63 | −0.40% | 9.9 | 9.8% | −1% | $12.50B |
| 167 | NAMSNewAmsterdam Pharma Company N.VHealthcare | $23.58 | +4.43% | 9.9 | 23.3% | +17% | $2.82B |
| 168 | ARDTArdent HealthHealthcare | $10.47 | −0.66% | 9.8 | 19.5% | +17% | $1.48B |
| 169 | LIVNLivaNovaHealthcare | $77.21 | +0.76% | 9.7 | 9.8% | +8% | $4.25B |
| 170 | ABCLAbCellera BiologicsHealthcare | $13.92 | +9.61% | 9.6 | 15.9% | −2% | $4.51B |
| 171 | AVLNAvalyn PharmaHealthcare | $28.32 | +0.85% | 9.6 | 10.3% | +8% | $1.26B |
| 172 | SEPNSepternaHealthcare | $39.74 | +5.22% | 9.5 | 9.9% | +6% | $1.85B |
| 173 | VIRVir BiotechnologyHealthcare | $10.51 | −1.41% | 9.5 | 14.9% | −8% | $1.78B |
| 174 | AGIOAgios PharmaceuticalsHealthcare | $33.42 | +2.58% | 9.5 | 13.4% | 0% | $2.00B |
| 175 | PBHPrestige Consumer HealthcareHealthcare | $46.93 | +0.69% | 9.5 | 10.3% | +5% | $2.22B |
| 176 | PRGOPERRIGOHealthcare | $15.10 | −2.08% | 9.3 | 16.4% | 0% | $2.10B |
| 177 | WHWKWhitehawk TherapeuticsHealthcare | $3.76 | +0.53% | 9.3 | 9.1% | −9% | $214.4M |
| 178 | OMEROmerosHealthcare | $19.43 | −3.24% | 9.3 | 19.5% | −2% | $1.41B |
| 179 | INVAInnovivaHealthcare | $21.23 | +2.36% | 9.3 | 10.3% | +3% | $1.53B |
| 180 | MASS908 DevicesHealthcare | $11.66 | +1.92% | 9.3 | 9.8% | −2% | $482.0M |
| 181 | CTMXCytomX TherapeuticsHealthcare | $2.69 | −0.37% | 9.3 | 19.3% | +15% | $586.1M |
| 182 | NVAXNovavaxHealthcare | $10.80 | +1.60% | 9.3 | 31.9% | +2% | $1.78B |
| 183 | OKUROnKure TherapeuticsHealthcare | $2.76 | −4.83% | 9.3 | 5.5% | +4% | $111.8M |
| 184 | EIKNEikon TherapeuticsHealthcare | $7.91 | −0.13% | 9.3 | 20.5% | +3% | $428.4M |
| 185 | RLMDRelmada TherapeuticsHealthcare | $3.79 | −1.04% | 9.3 | 16.6% | +6% | $404.3M |
| 186 | UFPTUFP TechnologiesHealthcare | $299.22 | +1.21% | 9.2 | 14.3% | 0% | $2.32B |
| 187 | URGNUroGen PharmaHealthcare | $40.90 | −1.09% | 9.2 | 13.7% | 0% | $2.00B |
| 188 | KROSKeros TherapeuticsHealthcare | $11.28 | −2.93% | 9.1 | 7.3% | +15% | $223.7M |
| 189 | PHATPhathom PharmaceuticalsHealthcare | $7.35 | +0.68% | 9.1 | 18.1% | −6% | $594.6M |
| 190 | ACHVAchieve Life SciencesHealthcare | $7.75 | +2.79% | 9.1 | 25.2% | −3% | $797.5M |
| 191 | ANROAlto NeuroscienceHealthcare | $26.66 | +0.64% | 9.1 | 16.0% | +9% | $1.05B |
| 192 | MNKDMannkindHealthcare | $3.35 | +0.30% | 9.1 | 10.5% | +11% | $1.08B |
| 193 | ELVNEnliven TherapeuticsHealthcare | $46.01 | +2.82% | 9.0 | 14.2% | 0% | $3.37B |
| 194 | PRLDPrelude Therapeutics IncorporatedHealthcare | $3.91 | +0.90% | 9.0 | 21.3% | +1% | $312.0M |
| 195 | ELDNEledon PharmaceuticalsHealthcare | $2.64 | −0.38% | 9.0 | 10.7% | +7% | $214.5M |
| 196 | TWSTTwist BioscienceHealthcare | $179.60 | −1.77% | 8.9 | 23.3% | +4% | $11.91B |
| 197 | KURAKura OncologyHealthcare | $10.61 | −1.39% | 8.8 | 19.0% | +10% | $943.9M |
| 198 | TRVITrevi TherapeuticsHealthcare | $14.40 | −0.07% | 8.8 | 12.3% | 0% | $2.05B |
| 199 | SDGRSchrodingerHealthcare | $29.50 | +2.25% | 8.7 | 21.3% | +1% | $2.21B |
| 200 | NPCENeuropaceHealthcare | $14.15 | +0.64% | 8.7 | 4.0% | +5% | $485.7M |
Data guard: 9 stocks withheld — NG (reported short interest is above 100% of float); EGO (reported short interest is above 100% of float); BNS (reported short interest is above 100% of float); AQN (reported short interest is above 100% of float); CAE (reported short interest is above 100% of float); GIL (reported short interest is above 100% of float); EPRX (reported short interest is above 100% of float); MFI (reported short interest is above 100% of float); CHRN (float record is implausibly small). They return once the float record is verified.
Method & sources
Computed after each close from Massive / Polygon prices (split-adjusted), SEC filings, FINRA short-interest settlements and FMP earnings dates. Rows are rebuilt every session; a stock appears only when every criterion is met with current data. Full methodology
Informational screen, not a recommendation.